Samlyn Capital, LLC Insmed Inc Transaction History
Samlyn Capital, LLC
- $6.21 Billion
- Q4 2024
A detailed history of Samlyn Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Samlyn Capital, LLC holds 159,064 shares of INSM stock, worth $12.3 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
159,064
Previous 211,498
24.79%
Holding current value
$12.3 Million
Previous $15.4 Million
28.87%
% of portfolio
0.18%
Previous 0.25%
Shares
17 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.01 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$985 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$552 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...